Syndax Pharmaceuticals Inc (SNDX)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | METZGER, MICHAEL A | Director, Chief Executive Officer | Common Stock | Disposal | 32,375 | 24.24 |
| Jul 8, 2026 | METZGER, MICHAEL A | Director, Chief Executive Officer | Stock Option (Right to buy) | Acquisition | 32,375 | 0 |
| Jul 8, 2026 | METZGER, MICHAEL A | Director, Chief Executive Officer | Common Stock | Acquisition | 32,375 | 6.38 |
| Jun 12, 2026 | BOTWOOD, NICHOLAS A.J. | Head of R&D, CMO | Stock options (Right to buy) | Acquisition | 31,235 | 0 |
| Jun 12, 2026 | BOTWOOD, NICHOLAS A.J. | Head of R&D, CMO | Common Stock | Acquisition | 31,235 | 13.82 |
| Jun 12, 2026 | BOTWOOD, NICHOLAS A.J. | Head of R&D, CMO | Common Stock | Disposal | 31,235 | 18.14 |
| Jun 11, 2026 | BOTWOOD, NICHOLAS A.J. | Head of R&D, CMO | Stock options (Right to buy) | Acquisition | 22,515 | 0 |
| Jun 11, 2026 | BOTWOOD, NICHOLAS A.J. | Head of R&D, CMO | Common Stock | Disposal | 34,280 | 18 |
| Jun 11, 2026 | BOTWOOD, NICHOLAS A.J. | Head of R&D, CMO | Common Stock | Acquisition | 22,515 | 13.82 |
| Jun 1, 2026 | GOLDAN, KEITH A. | Chief Financial Officer | Common Stock | Disposal | 1,177 | 18.99 |
| Jun 1, 2026 | METZGER, MICHAEL A | Director, Chief Executive Officer | Common Stock | Disposal | 6,847 | 18.99 |
| Feb 9, 2026 | GOLDAN, KEITH A. | Chief Financial Officer | Common Stock | Disposal | 3,410 | 21.028 |
| Feb 9, 2026 | METZGER, MICHAEL A | Director, Chief Executive Officer | Common Stock | Disposal | 17,159 | 21.028 |
| Feb 6, 2026 | GOLDAN, KEITH A. | Chief Financial Officer | Common Stock | Disposal | 2,082 | 20.62 |
| Feb 6, 2026 | METZGER, MICHAEL A | Director, Chief Executive Officer | Common Stock | Disposal | 7,412 | 20.62 |
| Feb 4, 2026 | HUBER, MARTIN H. JR. | Director | Common Stock | Acquisition | 24,000 | 0 |
| Feb 4, 2026 | KATKIN, KEITH | Director | Common Stock | Acquisition | 24,000 | 0 |
| Feb 4, 2026 | JARRETT, JENNIFER | Director | Common Stock | Acquisition | 24,000 | 0 |
| Feb 4, 2026 | GOLDAN, KEITH A. | Chief Financial Officer | Stock Options (Right to buy) | Acquisition | 118,000 | 20.43 |
| Feb 4, 2026 | METZGER, MICHAEL A | Director, Chief Executive Officer | Stock Options (Right to buy) | Acquisition | 440,000 | 20.43 |
| Feb 4, 2026 | GOLDAN, KEITH A. | Chief Financial Officer | Common Stock | Acquisition | 30,750 | 0 |
| Feb 4, 2026 | METZGER, MICHAEL A | Director, Chief Executive Officer | Common Stock | Acquisition | 144,600 | 0 |
| Feb 4, 2026 | RIZO, ALEKSANDRA | Director | Common Stock | Acquisition | 24,000 | 0 |
| Feb 4, 2026 | BOTWOOD, NICHOLAS A.J. | Head of R&D, CMO | Common Stock | Acquisition | 24,000 | 0 |
| Feb 4, 2026 | PODLESAK, DENNIS | Director | Common Stock | Acquisition | 48,000 | 0 |
| Feb 4, 2026 | BOTWOOD, NICHOLAS A.J. | Head of R&D, CMO | Common Stock | Acquisition | 36,000 | 0 |
| Feb 4, 2026 | METZGER, MICHAEL A | Director, Chief Executive Officer | Common Stock | Acquisition | 73,000 | 0 |
| Feb 4, 2026 | BOTWOOD, NICHOLAS A.J. | Head of R&D, CMO | Stock Options (Right to buy) | Acquisition | 144,700 | 20.43 |
| Feb 4, 2026 | GOLDAN, KEITH A. | Chief Financial Officer | Common Stock | Acquisition | 21,500 | 0 |
| Feb 4, 2026 | LEGAULT, PIERRE | Director | Common Stock | Acquisition | 24,000 | 0 |
| Jan 30, 2026 | GOLDAN, KEITH A. | Chief Financial Officer | Common Stock | Acquisition | 1,219 | 8.48 |
| Dec 1, 2025 | GOLDAN, KEITH A. | Chief Financial Officer | Common Stock | Disposal | 1,224 | 0 |